Global Growth Stocks With Insiders Owning 43% Earnings Growth
As global markets grapple with trade policy uncertainties and inflationary pressures, investors are closely monitoring economic indicators and central bank actions. Amidst this backdrop, companies with strong growth potential and substantial insider ownership can offer unique opportunities, as they often signal confidence from those closest to the business.
Name
Insider Ownership
Earnings Growth
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181)
23.3%
26%
Seojin SystemLtd (KOSDAQ:A178320)
32.1%
34.3%
Vow (OB:VOW)
13.1%
120.9%
Pharma Mar (BME:PHM)
11.8%
40.8%
Laopu Gold (SEHK:6181)
36.4%
43.7%
CD Projekt (WSE:CDR)
29.7%
41.3%
Elliptic Laboratories (OB:ELABS)
22.6%
88.2%
Nordic Halibut (OB:NOHAL)
29.8%
56.3%
Ascentage Pharma Group International (SEHK:6855)
17.9%
60.9%
Synspective (TSE:290A)
13.2%
37.4%
Click here to see the full list of 881 stocks from our Fast Growing Global Companies With High Insider Ownership screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Hyosung Heavy Industries Corporation manufactures and sells heavy electrical equipment both in South Korea and internationally, with a market cap of approximately ₩3.99 trillion.
Operations: The company's revenue segments include Heavy Industry at ₩3.47 trillion and Construction at ₩1.76 trillion.
Insider Ownership: 16.4%
Earnings Growth Forecast: 43% p.a.
Hyosung Heavy Industries demonstrates promising growth potential with earnings expected to grow significantly at 43% annually, outpacing the Korean market. Despite high volatility in its share price recently, the stock is trading at 46.4% below estimated fair value and analysts agree on a potential rise of 22.1%. The company's revenue is projected to grow faster than the market, though not exceeding 20% annually. Recent presentations at industry conferences indicate active engagement with investors.
Click to explore a detailed breakdown of our findings in Hyosung Heavy Industries' earnings growth report.
Our valuation report unveils the possibility Hyosung Heavy Industries' shares may be trading at a discount.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Beijing Enlight Media Co., Ltd. is involved in the investment, production, and distribution of film and television projects in China with a market cap of CN¥67.66 billion.
Operations: Beijing Enlight Media generates revenue primarily through its activities in film and television project investment, production, and distribution within China.
Insider Ownership: 12.1%
Earnings Growth Forecast: 39.4% p.a.
Beijing Enlight Media's earnings are forecast to grow significantly at 39.4% annually, surpassing the Chinese market's growth rate. Revenue is expected to increase at 19.5% per year, slightly below the high-growth threshold but still above market averages. Despite a highly volatile share price recently and a low projected return on equity of 10.8%, there has been no substantial insider trading activity in the past three months, indicating stability in insider sentiment.
Get an in-depth perspective on Beijing Enlight Media's performance by reading our analyst estimates report here.
Our valuation report unveils the possibility Beijing Enlight Media's shares may be trading at a premium.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Visional, Inc., along with its subsidiaries, offers human resources platform solutions in Japan and has a market cap of ¥270.32 billion.
Operations: The company generates revenue from its human resources platform solutions in Japan.
Insider Ownership: 39.2%
Earnings Growth Forecast: 15% p.a.
Visional's earnings are projected to grow at 15% annually, outpacing the JP market. Revenue growth is expected at 12.2% per year, exceeding the market average but below high-growth benchmarks. The stock trades significantly below its estimated fair value and analysts anticipate a price increase of 24.8%. With no recent insider trading activity, stability in insider sentiment is suggested, though revenue growth remains moderate compared to top-tier growth companies.
Unlock comprehensive insights into our analysis of Visional stock in this growth report.
Insights from our recent valuation report point to the potential undervaluation of Visional shares in the market.
Click this link to deep-dive into the 881 companies within our Fast Growing Global Companies With High Insider Ownership screener.
Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include KOSE:A298040 SZSE:300251 and TSE:4194.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
3 Global Penny Stocks With Market Caps Over US$400M To Watch
Global markets have been navigating a complex landscape, with U.S. stocks closing higher amid ongoing trade policy discussions and easing inflation rates. In this context, investors are increasingly looking for opportunities that balance affordability with potential growth. Penny stocks, though often seen as a relic of the past, continue to offer intriguing prospects; these typically smaller or newer companies can provide significant upside when backed by strong financials. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.525 A$71.7M ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ Foresight Group Holdings (LSE:FSG) £4.02 £452.42M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.70 SEK277.44M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.445 SGD180.35M ★★★★★☆ Tasmea (ASX:TEA) A$3.06 A$732.54M ★★★★★☆ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ LSL Property Services (LSE:LSL) £2.81 £290.33M ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.38 HK$50.26B ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Click here to see the full list of 5,595 stocks from our Global Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★★★ Overview: STI Education Systems Holdings, Inc., with a market cap of ₱14.24 billion, operates through its subsidiaries to offer a variety of educational services in the Philippines. Operations: The company generates revenue of ₱5.49 billion from its educational services, including schools, colleges, and universities in the Philippines. Market Cap: ₱14.24B STI Education Systems Holdings, Inc. demonstrates a stable financial position with revenue of ₱5.49 billion and net income growth to ₱1,600.84 million for the recent nine months. The company's earnings have grown by 49.2% over the past year, surpassing industry averages, although this is below its five-year average growth rate of 62.7%. Its net debt to equity ratio of 0.7% is satisfactory, and short-term assets exceed liabilities significantly. Despite a low return on equity at 17.7%, STI offers high-quality earnings and reliable dividends at 2.68%, trading well below estimated fair value with experienced management in place. Click to explore a detailed breakdown of our findings in STI Education Systems Holdings' financial health report. Gain insights into STI Education Systems Holdings' historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sinopec Shanghai Petrochemical Company Limited, along with its subsidiaries, engages in the manufacturing and sale of petroleum and chemical products in China, with a market capitalization of approximately HK$26.49 billion. Operations: No specific revenue segments are reported for the company. Market Cap: HK$26.49B Sinopec Shanghai Petrochemical Company Limited has shown resilience despite challenges, with recent strategic moves like the Steam Sales Contract with Baling New Materials potentially enhancing resource utilization and reducing costs. The company has become profitable in the past year, although its return on equity remains low at 0.6%. While earnings have declined over five years, they are forecast to grow significantly. The company's financial stability is supported by short-term assets exceeding liabilities and a strong cash position relative to debt, bolstered by a substantial share buyback program that reflects confidence in its valuation and future prospects. Dive into the specifics of Sinopec Shanghai Petrochemical here with our thorough balance sheet health report. Learn about Sinopec Shanghai Petrochemical's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Infund Holding Co., Ltd. operates in China, focusing on the production of micro enameled wire and veterinary vaccines, with a market cap of CN¥3.47 billion. Operations: Infund Holding Co., Ltd. has not reported any specific revenue segments. Market Cap: CN¥3.47B Infund Holding Co., Ltd. has shown significant revenue growth, reporting CN¥294.68 million for Q1 2025 compared to CN¥16.65 million a year ago, transitioning from a net loss to a net income of CN¥14.21 million. Despite being unprofitable in the past, the company has reduced its losses over five years by 26.2% annually and improved its debt-to-equity ratio from 11.3% to 1.9%. Short-term assets exceed liabilities, providing some financial stability; however, with less than a year of cash runway and negative return on equity (-12.88%), financial challenges persist amidst stable weekly volatility (8%). Click here and access our complete financial health analysis report to understand the dynamics of Infund Holding. Understand Infund Holding's track record by examining our performance history report. Investigate our full lineup of 5,595 Global Penny Stocks right here. Seeking Other Investments? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 24 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include PSE:STI SEHK:338 and SZSE:002141. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
10 hours ago
- Yahoo
HighTide Therapeutics And 2 Other Asian Penny Stocks To Watch Closely
Amidst a backdrop of fluctuating global trade policies and easing inflation, Asian markets have been navigating a complex economic landscape. For investors eyeing opportunities in smaller or newer companies, penny stocks—though an outdated term—still hold potential for growth at accessible price points. These stocks can offer notable value when backed by strong financials, making them intriguing options for those seeking hidden gems with promising long-term prospects. Name Share Price Market Cap Financial Health Rating Halcyon Technology (SET:HTECH) THB2.64 THB792M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.445 SGD180.35M ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.176 SGD35.06M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ BRC Asia (SGX:BEC) SGD3.13 SGD858.72M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.90 HK$3.28B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.39 HK$50.26B ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.04 HK$1.7B ★★★★★★ Click here to see the full list of 1,161 stocks from our Asian Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: HighTide Therapeutics, Inc. is a biopharmaceutical company focused on discovering, researching, developing, and commercializing therapies for metabolic and digestive diseases in Mainland China, with a market cap of HK$1.42 billion. Operations: HighTide Therapeutics, Inc. has not reported any specific revenue segments at this time. Market Cap: HK$1.42B HighTide Therapeutics, Inc., a pre-revenue biopharmaceutical company, recently announced positive Phase 3 trial results for its lead compound HTD1801 in treating type 2 diabetes mellitus. Despite its lack of revenue and current unprofitability, the company has a strong financial position with short-term assets exceeding liabilities and more cash than debt. The management team is experienced, although the board is relatively new. HighTide's stock remains highly volatile, reflecting typical penny stock characteristics. The upcoming NDA submission for HTD1801 could be pivotal if approved by China's regulatory authorities later this year. Take a closer look at HighTide Therapeutics' potential here in our financial health report. Gain insights into HighTide Therapeutics' past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Shandong Molong Petroleum Machinery Company Limited, along with its subsidiaries, focuses on the design, research and development, production, and sale of energy equipment products and services both in China and internationally, with a market cap of HK$3.06 billion. Operations: No specific revenue segments are reported for Shandong Molong Petroleum Machinery Company Limited. Market Cap: HK$3.06B Shandong Molong Petroleum Machinery has shown a mix of financial challenges and operational resilience. Despite being unprofitable, the company maintains a positive cash runway for over three years, supported by CN¥2 billion in short-term assets exceeding its liabilities. However, its high net debt to equity ratio of 201.3% and increased debt levels highlight financial strain. The recent earnings report shows improved revenue but a significant drop in net income compared to the previous year, indicating volatility typical of penny stocks. Management's lack of experience could impact strategic decisions as they navigate these complexities. Unlock comprehensive insights into our analysis of Shandong Molong Petroleum Machinery stock in this financial health report. Assess Shandong Molong Petroleum Machinery's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Chongqing Lummy Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and sale of pharmaceutical products in China with a market cap of CN¥3.92 billion. Operations: The company's revenue is primarily generated from its operations in China, amounting to CN¥812.87 million. Market Cap: CN¥3.92B Chongqing Lummy Pharmaceutical faces financial challenges typical of penny stocks, with a net loss of CN¥13.78 million reported for Q1 2025 despite revenue growth to CN¥198.4 million. The company is unprofitable but has improved its debt profile, reducing the debt-to-equity ratio from 74.9% to 18.6% over five years and maintaining more cash than total debt, providing a stable cash runway exceeding three years even if free cash flow declines. Short-term assets of CN¥1.5 billion comfortably cover liabilities, though ongoing losses necessitate careful management by its experienced leadership team averaging over eight years in tenure. Click to explore a detailed breakdown of our findings in Chongqing Lummy Pharmaceutical's financial health report. Review our historical performance report to gain insights into Chongqing Lummy Pharmaceutical's track record. Click this link to deep-dive into the 1,161 companies within our Asian Penny Stocks screener. Looking For Alternative Opportunities? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2511 SEHK:568 and SZSE:300006. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
Uncovering 3 Undiscovered Gems in the United Kingdom Market
The United Kingdom market has recently faced challenges, as reflected in the FTSE 100's decline following weak trade data from China, highlighting concerns over global economic recovery and its impact on UK companies. Despite these headwinds, there remain opportunities within the market for discerning investors who seek stocks with strong fundamentals and resilience to broader economic pressures. Name Debt To Equity Revenue Growth Earnings Growth Health Rating BioPharma Credit NA 7.22% 7.91% ★★★★★★ B.P. Marsh & Partners NA 29.42% 31.34% ★★★★★★ MS INTERNATIONAL NA 13.42% 56.55% ★★★★★★ Rights and Issues Investment Trust NA -7.87% -8.41% ★★★★★★ Andrews Sykes Group NA 2.08% 5.03% ★★★★★★ Nationwide Building Society 277.32% 10.61% 23.42% ★★★★★☆ FW Thorpe 2.95% 11.79% 13.49% ★★★★★☆ Goodwin 37.02% 9.75% 15.68% ★★★★★☆ AltynGold 73.21% 26.90% 31.85% ★★★★☆☆ Law Debenture 17.80% 11.81% 7.59% ★★★★☆☆ Click here to see the full list of 58 stocks from our UK Undiscovered Gems With Strong Fundamentals screener. Let's explore several standout options from the results in the screener. Simply Wall St Value Rating: ★★★★★★ Overview: Concurrent Technologies Plc, along with its subsidiaries, specializes in designing, developing, manufacturing, and marketing single board computers for system integrators and original equipment manufacturers globally, with a market cap of £184.88 million. Operations: The primary revenue stream for Concurrent Technologies comes from the design, manufacture, and supply of high-end embedded computer products, generating £40.32 million. The company's market cap stands at £184.88 million. Concurrent Technologies, a nimble player in the tech sector, showcases impressive growth with earnings surging 48.8% last year, outpacing the industry average of 26.2%. The company is debt-free for five years and maintains high-quality earnings, contributing to its robust financial health. Recent expansion plans include a new headquarters and manufacturing facility costing £5 million, funded from existing reserves. Despite significant insider selling recently, prospects remain bright with forecasted earnings growth at 17.76% annually. A proposed dividend increase to 1.1 pence per share further underscores confidence in continued profitability and shareholder value enhancement. Unlock comprehensive insights into our analysis of Concurrent Technologies stock in this health report. Review our historical performance report to gain insights into Concurrent Technologies''s past performance. Simply Wall St Value Rating: ★★★★★★ Overview: Macfarlane Group PLC designs, manufactures, and distributes protective packaging products to businesses in the United Kingdom and Europe, with a market capitalization of £190.38 million. Operations: The company's primary revenue streams are Packaging Distribution, contributing £228.76 million, and Manufacturing Operations, generating £47.46 million. Macfarlane Group, a nimble player in the packaging sector, is making strategic moves to strengthen its market position. The acquisition of Pitreavie enhances its footprint in Scotland's food and drink industry, potentially boosting gross margins through local manufacturing capabilities. With earnings growth at 3.7% last year, outpacing the industry average of -4.9%, Macfarlane shows resilience and adaptability. Its net debt to equity ratio of 1.6% reflects prudent financial management, while an EBIT coverage of interest payments by 8.4 times indicates robust profitability support. Despite insider selling recently, the company trades at a compelling discount to fair value estimates by 32%. Macfarlane Group's strategic acquisitions and sector diversification drive long-term growth. Click here to explore the full narrative on Macfarlane Group's investment thesis. Simply Wall St Value Rating: ★★★★★★ Overview: Pinewood Technologies Group PLC is a cloud-based dealer management software provider with operations spanning the United Kingdom, Europe, Africa, Asia, the Middle East, and other international markets; it has a market capitalization of £406.67 million. Operations: Pinewood Technologies Group generates revenue primarily through its cloud-based dealer management software services. The company operates across multiple regions, including the United Kingdom, Europe, Africa, Asia, and the Middle East. Pinewood Technologies Group, a dynamic player in the automotive software sector, is making waves with its strategic moves. Their acquisition of Seez AI promises to enhance cross-sell and upsell capabilities, potentially boosting revenue. Partnerships with UK giants like Marshalls and Lookers further strengthen their market position. Recent financials show sales at £31.2 million and net income of £5.7 million for the eleven months ending December 2024, reflecting robust performance despite a one-off £2.4 million loss impacting results. With earnings growth outpacing industry averages and debt-to-equity dropping from 103.8% to 0.5% over five years, Pinewood seems poised for continued expansion but must navigate international challenges carefully to sustain momentum. Pinewood Technologies Group's acquisition of Seez is poised to enhance revenue through improved cross-sell and upsell opportunities; click here to explore the full narrative on how this strategic move could impact the company's growth. Click this link to deep-dive into the 58 companies within our UK Undiscovered Gems With Strong Fundamentals screener. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:CNC LSE:MACF and LSE:PINE. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
